1. 2′-Fluoro-6′-methylene-carbocyclic adenosine phosphoramidate (FMCAP) prodrug: In vitro anti-HBV activity against the lamivudine–entecavir resistant triple mutant and its mechanism of action
2. aSurlaraux, D.; Dousson, C. B.; Parsy, C. C.US 2013/95063 A1 (Oct 12, 2012) .
3. bVerma, V.; Arasappa, N. A.; Njoroge, F. G.; Girijavall Abhan, V.; Bogen, S. L.; Dang, Q.; Olsen, D. B.WO 2013/9735 A1 (Jul 10, 2012) .
4. cHuang, Q.; Zhou, S.WO 2013/013009 A2 (Jul 19, 2012) .
5. dWang, G.; Kim, I. J.; Or, Y. S.US 2013/78217 A1 (Sep 21, 2012) .